<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01383382</url>
  </required_header>
  <id_info>
    <org_study_id>R01HL096624</org_study_id>
    <nct_id>NCT01383382</nct_id>
  </id_info>
  <brief_title>Transforming PCI Informed Consent Into an Evidence-based Decision-making Tool</brief_title>
  <acronym>PRISM</acronym>
  <official_title>Transforming PCI Informed Consent Into an Evidence-based Decision-making Tool</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Saint Luke's Health System</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Washington University School of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baylor Research Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Baystate Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Henry Ford Health System</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Kaiser Permanente</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Prairie Education and Research Cooperative</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Saint Luke's Health System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Using individualized patient estimates of procedural risks and benefits, this project will&#xD;
      transform the process of informed consent for coronary angioplasty into a dynamic educational&#xD;
      tool for patients and physicians and is a direct response to the Institute of Medicine's call&#xD;
      for a more evidence-based, efficient, patient-centered healthcare system. It is hypothesized&#xD;
      that patients will develop a greater understanding of their individual risks and benefits&#xD;
      from PCI, will be empowered to more actively engage in shared decision-making, as well as&#xD;
      have improved awareness of their responsibility to adhere to dual anti-platelet therapy if&#xD;
      treated with a drug eluting stent (risks for target vessel revascularization with bare metal&#xD;
      and drug eluting stents are also provided in the new consent form). It is also anticipated&#xD;
      that physicians, in turn, will use these individualized estimates to better discriminate&#xD;
      between risks and benefits among different bleeding avoidance therapies so as to improve the&#xD;
      safety and cost-effectiveness of PCI.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will test the impact of a new mechanism for eliciting informed consent from&#xD;
      patients undergoing percutaneous coronary intervention (PCI) on 1) patients' comprehension of&#xD;
      procedural risks/benefits and participation in shared decision-making; and 2) upon&#xD;
      clinicians' use of effective strategies to minimize the risk of bleeding at the time of PCI.&#xD;
      To facilitate these goals, we will prospectively provide each patients' risks for bleeding at&#xD;
      the time that the informed consent document is generated. This will be accomplished by&#xD;
      transforming the infrastructure of the informed consent process at participating study&#xD;
      centers using a novel, web-based system - the Personalized Risk Information Services Manager&#xD;
      (PRISM) - to generate individualized consent forms with estimates of risks and outcomes using&#xD;
      validated multivariable models from the American College of Cardiology's NCDR. The goals of&#xD;
      this study are to 1) identify barriers in implementing individualized consent forms in&#xD;
      clinical care and to test whether this novel consent process 2) improves the quality of the&#xD;
      informed consent process, 3) supports the more rational use of Bleeding Avoidance Therapies&#xD;
      (BATs), 4) reduces bleeding events after PCI, and 5) supports a more cost-effective PCI&#xD;
      procedure. This will be done using a pre-post design at 6 enrolling hospitals and comparing&#xD;
      changes in practice with contemporaneous controls matched from the broader NCDR Cath/PCI&#xD;
      registry.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2009</start_date>
  <completion_date type="Actual">September 2012</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">1399</enrollment>
  <condition>Non-emergent Percutaneous Coronary Intervention (PCI)</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Cardiac patients undergoing a non-emergent percutaneous coronary intervention (PCI)&#xD;
        procedure for their heart disease.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All patients receiving a PCI in a participating institution&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Previously enrolled in the PRISM&#xD;
&#xD;
          -  Does not speak English or Spanish&#xD;
&#xD;
          -  Dementia&#xD;
&#xD;
          -  Too ill to interview&#xD;
&#xD;
          -  Current prisoner&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John A Spertus, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Saint Luke's Hospital of Kansas City</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Kaiser Permanente</name>
      <address>
        <city>Oakland</city>
        <state>California</state>
        <zip>94612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Prairie Education and Research Cooperative</name>
      <address>
        <city>Springfield</city>
        <state>Illinois</state>
        <zip>62701</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baystate Medical Center</name>
      <address>
        <city>Springfield</city>
        <state>Massachusetts</state>
        <zip>01199</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Henry Ford Health System</name>
      <address>
        <city>Detroit</city>
        <state>Michigan</state>
        <zip>48202</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Saint Luke's Hospital of Kansas City</name>
      <address>
        <city>Kansas City</city>
        <state>Missouri</state>
        <zip>64111</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Barnes-Jewish Hospital/Washington University School of Medicine</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63130</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Baylor Research Institute</name>
      <address>
        <city>Plano</city>
        <state>Texas</state>
        <zip>75204</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2011</verification_date>
  <study_first_submitted>June 27, 2011</study_first_submitted>
  <study_first_submitted_qc>June 27, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2011</study_first_posted>
  <last_update_submitted>September 7, 2012</last_update_submitted>
  <last_update_submitted_qc>September 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2012</last_update_posted>
  <responsible_party>
    <name_title>John A. Spertus, MD, MPH</name_title>
    <organization>Saint Luke's Hospital of Kansas City</organization>
  </responsible_party>
  <keyword>Heart Diseases</keyword>
  <keyword>Cardiovascular Diseases</keyword>
  <keyword>Acute Myocardial Infarction</keyword>
  <keyword>Decision Making</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Informed Consent</keyword>
  <keyword>Quality of Care</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

